Новая классификация холестеатомы EAONO/JOS и хирургических вмешательств на среднем ухе SAMEO-ATO: актуальность и клиническая значимость

Пчеленок Е.В., Тарасова О.Ю., Косяков С.Я. Новая классификация холестеатомы EAONO/JOS и хирургических вмешательств на среднем ухе SAMEO-ATO: актуальность и клиническая значимость. Consilium Medicum. 2021;23(12):956–960. DOI: 10.26442/20751753.2021.12.201236

________________________________________________

Pchelenok EV, Tarasova OYu, Kosyakov SYa. New classification of EAONO/JOS cholesteatoma and SAMEO-ATO middle ear surgery: relevance and clinical significance. Consilium Medicum. 2021;23(12):956–960.
DOI: 10.26442/20751753.2021.12.201236

Читать PDF

Аннотация

Холестеатома среднего уха (ХСУ) является распространенной проблемой современной отологии. Европейская академия отологии и нейроотологии совместно с Японским отологическим обществом (EAONO/JOS) в 2017 г. опубликовали консенсусные рекомендации по определению, классификации и стадиям ХСУ. В 2018 г. под эгидой Международного общества по оценке результатов в отологии (The International Otology Outcome Group) представлена классификация хирургических вмешательств на среднем ухе. Ведущей проблемой хирургии ХСУ остается высокая частота рецидивирования, которая составляет от 5 до 32% в зависимости от типа хирургического вмешательства. Цель статьи – представить описание новой классификации ХСУ EAONO/JOS и хирургических вмешательств на среднем ухе SAMEO-ATO с анализом их возможной клинической значимости для определения риска рецидивирования холестеатомы, а также прогноза в отношении восстановления слуха после операции.

Ключевые слова: холестеатома среднего уха, классификация холестеатомы, стадии холестеатомы, хирургия среднего уха, клиническая значимость

________________________________________________

Middle ear cholesteatoma (MEC) is a common problem of modern otology. The European Academy of Otology and Neurootology in cooperation with the Japanese Otological Society (EAONO/JOS) published consensus recommendations on the definition, classification and stages of MEC in 2017. In 2018, the classification of middle ear surgery was presented under the auspices of the International Otology Outcome Group. The leading problem of MEC surgery remains the high recurrence rate, which ranges from 5 to 32% depending on the type of surgical intervention. The main purpose of this article is to describe the new EAONO/JOS classification of MEC and SAMEO-ATO middle ear surgical interventions with an analysis of their possible clinical significance in determining the risk of cholesteatoma recurrence as well as the prognosis for hearing recovery after surgery.

Keywords: middle ear cholesteatoma, cholesteatoma classification, stages of cholesteatoma, middle ear surgery, clinical significance

Полный текст

Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью Авторизуйтесь или зарегистрируйтесь.

Список литературы

1. Аникин М.И. Холестеатома среднего уха: определение, вопросы классификации и этиопатогенеза. Российская оториноларингология. 2016;82(3):16-23 [Anikin MI. Kholesteatoma srednego ukha: opredelenie, voprosy klassifikatsii i etiopatogeneza. Rossiiskaia otorinolaringologiia. 2016;82(3):16-23 (in Russian)].
2. Rutkowska J, Özgirgin N, Olszewska E. Cholesteatoma Definition and Classification: A Literature Review. J Int Adv Otol. 2017;13(2):266-71.
3. Aquino JE, Cruz Filho NA, de Aquino JN. Epidemiology of middle ear and mastoid cholesteatomas: study of 1146 cases. Braz J Otorhinolaryngol. 2011;77:341-7.
4. Wallis S, Atkinson H, Coatesworth AP. Chronic otitis media. Postgrad Med. 2015;127(4):391-5.
5. Kuo CL. Etiopathogenesis of acquired cholesteatoma: prominent theories and recent advances in biomolecular research. Laryngoscope. 2015;125(1):234-40.
6. Yung M, Tono T, Olszewska E, et al. EAONO/JOS Joint Consensus Statements on the Definitions, Classification and Staging of Middle Ear Cholesteatoma. J Int Adv Otol. 2017;13(1):1-8.
7. Gaillardin L, Lescanne E, Morinière S, et al. Residual cholesteatoma: prevalence and location. Follow-up strategy in adults. Eur Ann Otorhinolaryngol Head Neck Dis. 2012;129:136-40.
8. Ardic FN, Mengi E, Tümkaya F, et al. Correlation between Surgical Outcome and Stage of Acquired Middle Ear Cholesteatoma: Revalidation of the EAONO/JOS Staging System. J Int Adv Otol. 2020;16(1):34-9.
9. Lien CF. Staging of attic cholesteatoma. Chin Med J. 1984;33:438-42.
10. Dornhoffer JL, Gardner E. Prognostic factors in ossiculoplasty: A statistical staging system. Otol Neurotol. 2001;22:299-304.
11. Black B, Gutteridge I. Aquired cholesteatoma: Classification and outcomes. Otol Neurotol. 2011;32:992-5.
12. Belal A, Reda M, Mehanna A, et al. TMC: A new staging system for tympanomastoid cholesteatoma. Egyptian J Otolaryngol. 2012;28:12-6.
13. Kitahara T, Mishiro Y, Sakagami M, et al. Staging-based surgical results in chronic otitis media with cholesteatoma. Nippon Jibiinkoka Gakkai Kaiho (Tokyo). 2012;115:91-100.
14. Olszewska E, Rutkowska J, Özgirgin N. Consensus-Based Recommendations on the Definition and Classification of Cholesteatoma. J Int Adv Otol. 2015;11:81-7.
15. Tono T, Sakagami M, Kojima H, et al. Staging and classification criteria for middle ear cholesteatoma proposed by the Japan Otological Society. Auris Nasus Larynx. 2017;44(2):135-40.
16. Komori M, Tada T, Koizumi H, et al. Practical analysis of pars flaccida cholesteatoma with classification and staging system proposed by Japan Otological Society: a comparative study. Acta Otolaryngol. 2018;138(11):977-80.
17. Linder TE, Shah S, Martha AS, et al. Introducing the “ChOLE” Classification and Its Comparison to the EAONO/JOS Consensus Classification for Cholesteatoma Staging. Otol Neurotol. 2019;40(1):63-72.
18. James AL, Siu J, Borkhoff CM, et al. International Collaborative Assessment of the Validity of the EAONO-JOS Cholesteatoma Staging System: Confirmation of Validity and Reliability. Otol Neurotol. 2020;41(2):286-7.
19. Sabour S. International Collaborative Assessment of the Validity of the EAONO-JOS Cholesteatoma Staging System: Methodological Issues on Validity and Reliability. Otol Neurotol. 2020;41(2):285.
20. Motegi M, Yamamoto Y, Tada T, et al. Clinical Characteristics of Pars Tensa Cholesteatoma: A Comparative Study of Area-Based Classification Systems Proposed by the Japanese Otological Society and the European Academy of Otology – Neuro-Otology. J Int Adv Otol. 2019;15(2):184-8.
21. Fukuda A, Morita S, Nakamaru Y, et al. Short-Term Hearing Prognosis of Ossiculoplasty in Pars Flaccida Cholesteatoma Using the EAONO/JOS Staging System. J Int Adv Otol. 2019;15(1):2-7.
22. Olmedo MJ, Ropero RF, Sánchez GS. Cholesteatoma: Influence of surgical technique and EAONO/JOS stage on audiological results. Acta Otorrinolaringol Esp. 2021:S0001-6519(21)00042-X.
23. Van der Toom H, van der Schroeff MP, Janssen J, et al. A Retrospective Analysis and Comparison of the STAM and STAMCO Classification and EAONO/JOS Cholesteatoma Staging System in Predicting Surgical Treatment Outcomes of Middle Ear Cholesteatoma. Otol Neurotol. 2020;41(4):e468-74.
24. Angeli S, Shahal D, Brown CS, et al. Predicting Recidivism for Acquired Cholesteatoma: Evaluation of a Current Staging System. Otol Neurotol. 2020;41(10):1391-6.
25. Eggink MC, de Wolf MJF, Ebbens FA, et al. Evaluation of Long-term Cholesteatoma Recidivism: Using the JOS, EAONO-JOS, and STAMCO Cholesteatoma Staging Systems. Otol Neurotol. 2021;42(7):1031-8.
26. Yung M, James A, Merkus P, et al. International Otology Outcome Group and the International Consensus on the Categorization of Tympanomastoid Surgery. J Int Adv Otol. 2018;14(2):216-26.
27. Pontillo V, Damiani M, Graziano G, et al. Correlation between functional outcome and the SAMEO-ATO framework. Eur Arch Otorhinolaryngol. 2021. DOI:10.1007/s00405-021-07000-3
28. Cacco T, Africano S, Gaglio G, et al. Correlation between peri-operative complication in middle ear cholesteatoma surgery using STAMCO, ChOLE, and SAMEO-ATO classifications. Eur Arch Otorhinolaryngol. 2021. DOI:10.1007/s00405-021-06679-8

________________________________________________

1. Anikin MI. Kholesteatoma srednego ukha: opredelenie, voprosy klassifikatsii i etiopatogeneza. Rossiiskaia otorinolaringologiia. 2016;82(3):16-23 (in Russian).
2. Rutkowska J, Özgirgin N, Olszewska E. Cholesteatoma Definition and Classification: A Literature Review. J Int Adv Otol. 2017;13(2):266-71.
3. Aquino JE, Cruz Filho NA, de Aquino JN. Epidemiology of middle ear and mastoid cholesteatomas: study of 1146 cases. Braz J Otorhinolaryngol. 2011;77:341-7.
4. Wallis S, Atkinson H, Coatesworth AP. Chronic otitis media. Postgrad Med. 2015;127(4):391-5.
5. Kuo CL. Etiopathogenesis of acquired cholesteatoma: prominent theories and recent advances in biomolecular research. Laryngoscope. 2015;125(1):234-40.
6. Yung M, Tono T, Olszewska E, et al. EAONO/JOS Joint Consensus Statements on the Definitions, Classification and Staging of Middle Ear Cholesteatoma. J Int Adv Otol. 2017;13(1):1-8.
7. Gaillardin L, Lescanne E, Morinière S, et al. Residual cholesteatoma: prevalence and location. Follow-up strategy in adults. Eur Ann Otorhinolaryngol Head Neck Dis. 2012;129:136-40.
8. Ardic FN, Mengi E, Tümkaya F, et al. Correlation between Surgical Outcome and Stage of Acquired Middle Ear Cholesteatoma: Revalidation of the EAONO/JOS Staging System. J Int Adv Otol. 2020;16(1):34-9.
9. Lien CF. Staging of attic cholesteatoma. Chin Med J. 1984;33:438-42.
10. Dornhoffer JL, Gardner E. Prognostic factors in ossiculoplasty: A statistical staging system. Otol Neurotol. 2001;22:299-304.
11. Black B, Gutteridge I. Aquired cholesteatoma: Classification and outcomes. Otol Neurotol. 2011;32:992-5.
12. Belal A, Reda M, Mehanna A, et al. TMC: A new staging system for tympanomastoid cholesteatoma. Egyptian J Otolaryngol. 2012;28:12-6.
13. Kitahara T, Mishiro Y, Sakagami M, et al. Staging-based surgical results in chronic otitis media with cholesteatoma. Nippon Jibiinkoka Gakkai Kaiho (Tokyo). 2012;115:91-100.
14. Olszewska E, Rutkowska J, Özgirgin N. Consensus-Based Recommendations on the Definition and Classification of Cholesteatoma. J Int Adv Otol. 2015;11:81-7.
15. Tono T, Sakagami M, Kojima H, et al. Staging and classification criteria for middle ear cholesteatoma proposed by the Japan Otological Society. Auris Nasus Larynx. 2017;44(2):135-40.
16. Komori M, Tada T, Koizumi H, et al. Practical analysis of pars flaccida cholesteatoma with classification and staging system proposed by Japan Otological Society: a comparative study. Acta Otolaryngol. 2018;138(11):977-80.
17. Linder TE, Shah S, Martha AS, et al. Introducing the “ChOLE” Classification and Its Comparison to the EAONO/JOS Consensus Classification for Cholesteatoma Staging. Otol Neurotol. 2019;40(1):63-72.
18. James AL, Siu J, Borkhoff CM, et al. International Collaborative Assessment of the Validity of the EAONO-JOS Cholesteatoma Staging System: Confirmation of Validity and Reliability. Otol Neurotol. 2020;41(2):286-7.
19. Sabour S. International Collaborative Assessment of the Validity of the EAONO-JOS Cholesteatoma Staging System: Methodological Issues on Validity and Reliability. Otol Neurotol. 2020;41(2):285.
20. Motegi M, Yamamoto Y, Tada T, et al. Clinical Characteristics of Pars Tensa Cholesteatoma: A Comparative Study of Area-Based Classification Systems Proposed by the Japanese Otological Society and the European Academy of Otology – Neuro-Otology. J Int Adv Otol. 2019;15(2):184-8.
21. Fukuda A, Morita S, Nakamaru Y, et al. Short-Term Hearing Prognosis of Ossiculoplasty in Pars Flaccida Cholesteatoma Using the EAONO/JOS Staging System. J Int Adv Otol. 2019;15(1):2-7.
22. Olmedo MJ, Ropero RF, Sánchez GS. Cholesteatoma: Influence of surgical technique and EAONO/JOS stage on audiological results. Acta Otorrinolaringol Esp. 2021:S0001-6519(21)00042-X.
23. Van der Toom H, van der Schroeff MP, Janssen J, et al. A Retrospective Analysis and Comparison of the STAM and STAMCO Classification and EAONO/JOS Cholesteatoma Staging System in Predicting Surgical Treatment Outcomes of Middle Ear Cholesteatoma. Otol Neurotol. 2020;41(4):e468-74.
24. Angeli S, Shahal D, Brown CS, et al. Predicting Recidivism for Acquired Cholesteatoma: Evaluation of a Current Staging System. Otol Neurotol. 2020;41(10):1391-6.
25. Eggink MC, de Wolf MJF, Ebbens FA, et al. Evaluation of Long-term Cholesteatoma Recidivism: Using the JOS, EAONO-JOS, and STAMCO Cholesteatoma Staging Systems. Otol Neurotol. 2021;42(7):1031-8.
26. Yung M, James A, Merkus P, et al. International Otology Outcome Group and the International Consensus on the Categorization of Tympanomastoid Surgery. J Int Adv Otol. 2018;14(2):216-26.
27. Pontillo V, Damiani M, Graziano G, et al. Correlation between functional outcome and the SAMEO-ATO framework. Eur Arch Otorhinolaryngol. 2021. DOI:10.1007/s00405-021-07000-3
28. Cacco T, Africano S, Gaglio G, et al. Correlation between peri-operative complication in middle ear cholesteatoma surgery using STAMCO, ChOLE, and SAMEO-ATO classifications. Eur Arch Otorhinolaryngol. 2021. DOI:10.1007/s00405-021-06679-8

Авторы

Е.В. Пчеленок*, О.Ю. Тарасова, С.Я. Косяков

ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России, Москва, Россия
*epchelenok@yandex.ru

________________________________________________

Ekaterina V. Pchelenok*, Olga Yu. Tarasova, Sergey Ya. Kosyakov

Russian Medical Academy of Continuous Professional Education, Moscow, Russia
*epchelenok@yandex.ru

Назад к списку

Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.